丹参酮ⅡA磺酸钠注射液在急性心肌梗死中的应用

目的观察丹参酮ⅡA磺酸钠(STS)注射液治疗急性心肌梗死(AMI)的疗效。方法94例AMI患者随机分为观察组46例和对照组48例。对照组用常规治疗方法,观察组在常规治疗方法的基础上,加用STS注射液。结果治疗2周后观察组左室功能好转,梗死后心绞痛发生率下降,与对照组比较有显著性差异,两组心律失常、住院病死率无显著性差异。结论STS注射液治疗AMI可改善左室功能及心肌缺血,临床应用安全有效。

Objective To observe the effect of Sodium tanshinone IIA sulfonate(STS) injection in treating acute myocardiac infarction (AMI). Methods 94 cases of AMI had been randomly divided into two groups: a test (46 cases) and a controlled (48 cases). The latter had been treated by routine treatment and the former had been added STS injection. Results In the test the cardiac function had been improved, incidence rate of post-anginapectoris had been decreased. The differences was significant as compared with the controlled. The differences of arrhythmia and in-hospital mortality rate was not significant between two groups. Conclusions STS injection can be founded to improve left heart function and myocardial ischemia, clinical application in treatingAMI was safe and effective.